These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6463419)

  • 21. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
    Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
    Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
    [No Abstract]   [Full Text] [Related]  

  • 22. [The electrogram of the bundle of His. III. Supraventricular and ventricular paroxysmal tachycardias].
    Gizzi JC; Kormann DS; Büchler JR; Sousa JE
    Arq Bras Cardiol; 1981 Nov; 37(5):409-24. PubMed ID: 7347192
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
    Swiryn S; Bauernfeind RA; Wyndham CR; Dhingra RC; Palileo E; Strasberg B; Rosen KM
    Circulation; 1981 Jul; 64(1):169-75. PubMed ID: 7237716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined effects of cordarone and ritmilen on the contractile function of the myocardium after intravenous and oral administration of loading doses].
    Gushchin IV; Gimrikh EO; Volkova TG; Chernov VI
    Kardiologiia; 1988 Oct; 28(10):103-4. PubMed ID: 3226038
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of verapamil on the induction and maintenance of paroxysmal supraventricular tachycardias].
    García Civera R; Sanjuán Máñez R; Morell Cabedo S; Miralles Serrano L; García-Sacristán Fernández J; Llavador Sanchís J
    Rev Esp Cardiol; 1983; 36(4):319-28. PubMed ID: 6647961
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of junctional tachycardias in the Lown-Ganong-Levine syndrome.
    Ward DE; Camm J
    Am Heart J; 1983 Jan; 105(1):169-75. PubMed ID: 6849236
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of frequent stimulation of the left atrium via the esophagus in stopping supraventricular (recurrent) paroxysmal tachycardia].
    Lukoshiavichiute AI; Gedrimene DA
    Anesteziol Reanimatol; 1983; (1):56-60. PubMed ID: 6846904
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intranodal reentrant tachycardia].
    Perrot B; Faivre G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1263-76. PubMed ID: 6797364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Supraventricular paroxysmal tachycardias. Electrophysiological studies].
    Mori A; Caporicci D; Buja GF
    Minerva Med; 1983 Dec; 74(47-48):2829-33. PubMed ID: 6657123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 31. Ventricular Wenckebach after intravenous therapy with class I antiarrhythmic agents.
    Lau CP; Griffith MJ; Camm AJ
    Int J Cardiol; 1988 Jul; 20(1):141-4. PubMed ID: 3136088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of AV reciprocating tachycardia, using a concealed bundle of Kent, and paroxysmal atrial fibrillation in neurocardiogenic syncope].
    Fazekas T; Halmai L; Kardos A; Rudas L
    Orv Hetil; 1996 Aug; 137(33):1815-9. PubMed ID: 8927334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Supraventricular paroxysmal tachycardias in patients without Wolff-Parkinson-White syndrome].
    Delgado M; Fajuri A; Chamorro H; Kandora H; Rosselot E
    Rev Med Chil; 1982 Mar; 110(3):218-23. PubMed ID: 7156568
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics.
    Fujiki A; Yoshida S; Tani M; Inoue H
    Am J Cardiol; 1994 Aug; 74(3):282-3. PubMed ID: 8037138
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of paroxysmal supraventricular tachycardia (author's transl)].
    González R
    Rev Med Chil; 1981 Mar; 109(3):246-51. PubMed ID: 7280410
    [No Abstract]   [Full Text] [Related]  

  • 36. Atrioventricular nodal reentrant paroxysmal supraventricular tachycardia.
    Littmann L; Tenczer J; Fenyvesi T
    Arch Intern Med; 1984 Jan; 144(1):129-31. PubMed ID: 6691748
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary edema: a complication of metaraminol treatment of paroxysmal supraventricular tachycardia.
    Laniado S; Kronzon I; Mehta SS
    Isr J Med Sci; 1974 May; 10(5):504-8. PubMed ID: 4415385
    [No Abstract]   [Full Text] [Related]  

  • 39. Fentanyl added to propofol anesthesia elongates sinus node recovery time in pediatric patients with paroxysmal supraventricular tachycardia.
    Fujii K; Iranami H; Nakamura Y; Hatano Y
    Anesth Analg; 2009 Feb; 108(2):456-60. PubMed ID: 19151272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with the ultrasonic destruction of accessory conduction tracts in patients with frequent attacks of paroxysmal tachycardia].
    Shumakov VI; Kolpakov EV; Khubutiia MSh; Chachikian LR
    Grudn Khir; 1985; (2):43-7. PubMed ID: 3988110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.